HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2

Benzinga · 2d ago
HC Wainwright & Co. analyst Yi Chen maintains Envoy Medical (NASDAQ:COCH) with a Buy and lowers the price target from $2.5 to $2.